This is the ninth session of PhD Plus Commercialization skills series
The "derisking" of early stage fundraising also involves a wide variety of opportunities and protections found in the term sheets agreed upon between founders and investors. We will return to the story of Genentech and Kleiner Perkins to understand how these terms impact both founders and investors as the company grows and in the event of an exit.
David Touve, Senior Director, Applied Innovations and New Ventures, Batten Institute, Darden School of Business
Register here by Friday, Jan 28